Patents by Inventor Huapeng Feng

Huapeng Feng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ADJUVANT AND VACCINE CONTAINING ADJUVANT
    Publication number: 20240261398
    Abstract: The present invention is intended to provide an adjuvant having high safety to living bodies and an action to sufficiently reinforce immune function, and a vaccine comprising the adjuvant. Specifically, the present invention relates to 34 novel adjuvant candidate compounds, which have been identified by screening 145 food additives and 51 injection additives, using, as indicators, an increase in the antibody titer against influenza virus and a protective effect against infection with influenza virus, and then selecting those having the function of increasing the antiviral antibody titer in blood and the protective effect against viral infection. In addition, the present invention also relates to a vaccine comprising these adjuvant candidate compounds.
    Type: Application
    Filed: April 12, 2024
    Publication date: August 8, 2024
    Applicant: The University of Tokyo
    Inventors: Yoshihiro KAWAOKA, Huapeng FENG, Tokiko WATANABE, Makoto YAMASHITA
  • ADJUVANT AND VACCINE CONTAINING ADJUVANT
    Publication number: 20230210987
    Abstract: The present invention is intended to provide an adjuvant having high safety to living bodies and an action to sufficiently reinforce immune function, and a vaccine comprising the adjuvant. Specifically, the present invention relates to 34 novel adjuvant candidate compounds, which have been identified by screening 145 food additives and 51 injection additives, using, as indicators, an increase in the antibody titer against influenza virus and a protective effect against infection with influenza virus, and then selecting those having the function of increasing the antiviral antibody titer in blood and the protective effect against viral infection. In addition, the present invention also relates to a vaccine comprising these adjuvant candidate compounds.
    Type: Application
    Filed: March 10, 2023
    Publication date: July 6, 2023
    Applicant: The University of Tokyo
    Inventors: Yoshihiro KAWAOKA, Huapeng FENG, Tokiko WATANABE, Makoto YAMASHITA
  • ADJUVANT AND VACCINE CONTAINING ADJUVANT
    Publication number: 20210106680
    Abstract: The present invention is intended to provide an adjuvant having high safety to living bodies and an action to sufficiently reinforce immune function, and a vaccine comprising the adjuvant. Specifically, the present invention relates to 34 novel adjuvant candidate compounds, which have been identified by screening 145 food additives and 51 injection additives, using, as indicators, an increase in the antibody titer against influenza virus and a protective effect against infection with influenza virus, and then selecting those having the function of increasing the antiviral antibody titer in blood and the protective effect against viral infection. In addition, the present invention also relates to a vaccine comprising these adjuvant candidate compounds.
    Type: Application
    Filed: March 26, 2019
    Publication date: April 15, 2021
    Applicant: The University of Tokyo
    Inventors: Yoshihiro Kawaoka, Huapeng Feng, Tokiko Watanabe, Makoto Yamashita